Carnegie Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CARNEGIE, and what generic and branded alternatives to CARNEGIE drugs are available?
CARNEGIE has eight approved drugs.
Drugs and US Patents for Carnegie
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carnegie | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 202077-001 | Feb 11, 2013 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Carnegie | RASAGILINE MESYLATE | rasagiline mesylate | TABLET;ORAL | 201942-001 | Nov 18, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Carnegie | ETRAVIRINE | etravirine | TABLET;ORAL | 215402-002 | Apr 13, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Carnegie | AMINOCAPROIC ACID | aminocaproic acid | TABLET;ORAL | 213928-001 | Feb 12, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Carnegie | ETRAVIRINE | etravirine | TABLET;ORAL | 215402-001 | Apr 13, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Carnegie | FAMOTIDINE | famotidine | FOR SUSPENSION;ORAL | 217137-001 | Jul 7, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Carnegie | PRIMIDONE | primidone | TABLET;ORAL | 218366-002 | Jan 23, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |